Dialysis; Complications

Nephrology
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Aura Biosciences
Aura BiosciencesMA - Boston
1 program
Immune Response Following COVID-19 in Hemodialysis PatientsN/A1 trial
Active Trials
NCT05307601CompletedEst. Oct 2021
Voyager Therapeutics
1 program
VenaSureN/A1 trial
Active Trials
NCT05490225RecruitingEst. Mar 2027

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
Voyager TherapeuticsVenaSure
Aura BiosciencesImmune Response Following COVID-19 in Hemodialysis Patients

Clinical Trials (2)

Access Cannulation Trial II

Start: Apr 2025Est. completion: Mar 2027
N/ARecruiting
NCT05307601Aura BiosciencesImmune Response Following COVID-19 in Hemodialysis Patients

Immune Response Following COVID-19 in Hemodialysis Patients

Start: Sep 2020Est. completion: Oct 2021
N/ACompleted

Related Jobs in Nephrology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space